amolytpharma.com | Amolyt Pharma - Advancing peptides for the treatment of rare endocrine and metabolic

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /cart Disallow: /wishlist Disallow: /checkout Disallow: /my-account Disallow: /?orderby Disallow: /?filter Disallow: /add-to-cart=* Disallow: /?add_do_wishlist= Allow: /wp-admin/admin-ajax.php Crawl-delay: 10 User-agent: PetalBot Disallow: / User-agent: SemrushBot Disallow: / User-agent: AhrefsBot Disallow: / Sitemap:

Meta Tags

Title	Amolyt Pharma - Advancing peptides for the treatment of rare endocrine and metabolic
Description	Advancing peptides for the treatment of rare endocrine and related We are building on our team’s established expertise in therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and metabolic
Keywords	N/A

Server Information

WebSite	amolytpharma.com
Host IP	164.90.176.158
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

amolytpharma.com Valuation

US$5,454,528

Last updated: 2023-05-09 08:14:48

amolytpharma.com has Semrush global rank of 1,940,462. amolytpharma.com has an estimated worth of US$ 5,454,528, based on its estimated Ads revenue. amolytpharma.com receives approximately 629,369 unique visitors each day. Its web server is located in United States, with IP address 164.90.176.158. According to SiteAdvisor, amolytpharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$5,454,528
Daily Ads Revenue	US$5,035
Monthly Ads Revenue	US$151,049
Yearly Ads Revenue	US$1,812,582
Daily Unique Visitors	41,958
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
amolytpharma.com.	A	3600	IP: 164.90.176.158
amolytpharma.com.	NS	86400	NS Record: ns2.bdm.microsoftonline.com.
amolytpharma.com.	NS	86400	NS Record: ns3.bdm.microsoftonline.com.
amolytpharma.com.	NS	86400	NS Record: ns4.bdm.microsoftonline.com.
amolytpharma.com.	NS	86400	NS Record: ns1.bdm.microsoftonline.com.
amolytpharma.com.	MX	3600	MX Record: 0 amolytpharma-com.mail.protection.outlook.com.
amolytpharma.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all
amolytpharma.com.	TXT	3600	TXT Record: mscid=PgBqG8vbF2Nei4k0/Ct1eXpba/kd7ALIe+xm0Pv4xtzAfAJ8c6ancTUZTHq5HucGl0l8KGX/86MiYphnl25ahw==

HtmlToTextCheckTime:2023-05-09 08:14:48

Main Menu ABOUT US PROGRAMS Pipeline Eneboparatide: Hypoparathyroidism AZP-3813: Acromegaly PATIENTS NEWS CAREERS CONTACT US World Hypopara Awareness Day is June 1! Join us in raising awareness for people living with hypoparathyroidism and share this link . Amolyt Pharma Announces Abstracts Accepted for Presentation at ECE and ENDO May 5, 2023 Download a PDF: EN or FR Advancing peptides for the treatment of rare endocrine and related diseases We are a clinical stage, global company, building on our team’s established expertise to transform the lives of patients living with rare endocrine and related diseases. PROGRAMS Eneboparatide Our lead clinical candidate is a potentially clinically superior therapeutic peptide in development for hypoparathyroidism. Learn more about eneboparatide » Eneboparatide (red) bound to the PTH1 receptor. Adapted from Zhao et al. Science 364:138, 2019. Image generated with the PyMOL Molecular Graphics System, Version 2.3.2 Schrödinger, LLC. AZP-3813

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sun, 31 Oct 2021 13:06:15 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://amolytpharma.com/

HTTP/2 200 
server: nginx
date: Sun, 31 Oct 2021 13:06:15 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
set-cookie: PHPSESSID=febe20d238a5e20b487866ee4df9764e; path=/
expires: Thu, 19 Nov 1981 08:52:00 GMT
cache-control: no-store, no-cache, must-revalidate
pragma: no-cache
set-cookie: uael_visitor=1; expires=Wed, 26-Oct-2022 12:37:23 GMT; Max-Age=31104000; path=/
x-pingback: https://amolytpharma.com/xmlrpc.php
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-cache: HIT

amolytpharma.com Whois Information

Domain Name: AMOLYTPHARMA.COM
Registry Domain ID: 2516742683_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.register.it
Registrar URL: http://www.register.it
Updated Date: 2021-04-21T07:05:49Z
Creation Date: 2020-04-20T07:18:32Z
Registry Expiry Date: 2022-04-20T07:18:32Z
Registrar: Register SPA
Registrar IANA ID: 168
Registrar Abuse Contact Email: abuse@register.it
Registrar Abuse Contact Phone: +39.05520021555
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.BDM.MICROSOFTONLINE.COM
Name Server: NS2.BDM.MICROSOFTONLINE.COM
Name Server: NS3.BDM.MICROSOFTONLINE.COM
Name Server: NS4.BDM.MICROSOFTONLINE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-18T22:58:04Z <<<

amolytpharma.com valuation and analysis